StockTipsArenaBeta

BUY Shilpa Medicare Limited — Kunal Saraogi

BUYShilpa Medicare Limited
Shilpa Medicare share price target & all analyst calls

byKunal SaraogiHorizon: NA (inferred 1 year)6 Nov 2026via Zee Business (Live)

Entry₹942.75Inferred
Target₹1,160
Total upside +23.04%
Stop lossNot given
CMP₹942.351d ago
Active-0.04%+23.10%upside left 12 mo left
Follow Kunal Saraogi for new callsGet alertsWatch SHILPAMED for new buy/sell callsGet alertsSee 2 other Long-term calls on SHILPAMEDSee 541 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Nov, 5:27 pm IST
11 supporting2 neutral2 opposing
Supports the BUY call (11)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·6 Nov · yesterday

Shilpa Medicare Q2 results: Net profit jumps 80%, revenue rises 43%

NewsCnbc-Tv18·5 Nov · 2d ago

(opens in new tab)

2 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·5 Nov · 2d ago

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·30 Oct · 1w ago

Dr Reddy's stock could rise 10-15% if a major biosimilar gets approved in December: Systematix

NewsCnbc-Tv18·27 Oct · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Shilpa Medicare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·5 Nov · 2d ago

(opens in new tab)
Weighs against the BUY call (2)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Shilpa Medicare

All analyst calls on Shilpa Medicare

More from Kunal Saraogi

Every call and its outcome